Forgot your password?

Forgot your username?

Access Pharmaceuticals Biotech Specialty Pharma

2600 Stemmons Freeway, Suite 176
Dallas, TX 75207-2107 USA
Click for website
Research Sector Biotech Specialty Pharma
Summary Description A biopharmaceutical company that develops products for the care of cancer patients.

Click here for Financial Data Keywordssynthetic polymer-targeted delivery, vitamin-mediated targeted delivery, vitamin-mediated oral delivery, bioerodible hydrogel technology, nanoparticles and nanoparticle networks, hydrogel particle aggregate technology, Residerm topical delivery, carbohydrate, cancer, ACCP


Access Pharmaceuticals specializes in cancer and supportive care products that are largely based in proprietary nanopolymer technologies. Access has received FDA approval for and markets MuGard�?�......view more

Products / Services

MuGard - FDA-approved for management of oral mucositis; ProLindac - proprietary DACH platinum chemotherapy; Thiarabine - proprietary nucleoside analogue for leukemia/lymphoma; Cobalamin oral drug a......view more

Technology / Differentiation

Polymer Chemistry; drug delivery technology; cobalamin oral drug delivery; cobalamin targeted drug delivery;...view more

Market / Customers

Global pharma market......view more

Competitors / Substitutes / Alternatives

Biovail Corporation, Bristol-Myers Squibb Co., Endo Pharmaceuticals Holdings Inc....view more


Approved, Phase 2, preclinical...view more